Travoprost 3-Month Safety and Efficacy Study

NCT01453855 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1099

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost ophthalmic solution, 0.003%
DRUG: Travoprost ophthalmic solution, 0.004%

Sponsor

Alcon Research